Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
1.600
-0.140 (-8.05%)
At close: Dec 20, 2024, 4:00 PM
1.550
-0.050 (-3.13%)
After-hours: Dec 20, 2024, 7:01 PM EST
Mersana Therapeutics Employees
Mersana Therapeutics had 123 employees as of December 31, 2023. The number of employees decreased by 105 or -46.05% compared to the previous year.
Employees
123
Change (1Y)
-105
Growth (1Y)
-46.05%
Revenue / Employee
$283,228
Profits / Employee
-$606,659
Market Cap
197.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
LifeMD | 211 |
Precigen | 202 |
biote | 194 |
Utah Medical Products | 190 |
Nautilus Biotechnology | 167 |
Alpha Tau Medical | 121 |
Fulcrum Therapeutics | 76 |
Ocugen | 65 |
MRSN News
- 2 days ago - Mersana Therapeutics: We're About To Find Out If ADC Platform Is More Tolerable - Seeking Alpha
- 5 weeks ago - Mersana Therapeutics, Inc. (MRSN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024 - GlobeNewsWire
- 4 months ago - Mersana Therapeutics, Inc. (MRSN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024 - GlobeNewsWire
- 7 months ago - Mersana Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire